Walleye Trading LLC Amicus Therapeutics, Inc. Call Options Transaction History

Walleye Trading LLC

$46.7 Billion
Q3 2024

Call Options

22 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 14, 2024	SELL	$9.97 - $14.52 $78,763 - $114,708	-7,900 Reduced 76.7%	2,400 $34,000
Q3 2023 Nov 14, 2023	BUY	$11.78 - $13.86 $3,534 - $4,158	300 Added 3.0%	10,300 $125,000
Q2 2023 Aug 14, 2023	SELL	$10.72 - $13.3 $1,072 - $1,330	-100 Reduced 0.99%	10,000 $125,000
Q1 2023 May 15, 2023	BUY	$10.91 - $13.54 $85,098 - $105,612	7,800 Added 339.13%	10,100 $112,000
Q4 2022 Feb 14, 2023	SELL	$9.89 - $12.7 $71,208 - $91,440	-7,200 Reduced 75.79%	2,300 $28,000
Q3 2022 Nov 14, 2022	SELL	$9.82 - $12.75 $361,376 - $469,200	-36,800 Reduced 79.48%	9,500 $99,000
Q2 2022 Aug 08, 2022	SELL	$6.23 - $11.12 $107,779 - $192,376	-17,300 Reduced 27.2%	46,300 $497,000
Q1 2022 May 16, 2022	BUY	$7.89 - $12.48 $214,608 - $339,456	27,200 Added 74.73%	63,600 $602,000
Q4 2021 Feb 14, 2022	SELL	$9.82 - $12.44 $863,178 - $1.09 Million	-87,900 Reduced 70.72%	36,400 $420,000
Q3 2021 Nov 15, 2021	BUY	$8.74 - $11.84 $181,792 - $246,272	20,800 Added 20.1%	124,300 $1.19 Million
Q2 2021 Aug 16, 2021	BUY	$8.71 - $10.72 $458,146 - $563,872	52,600 Added 103.34%	103,500 $998,000
Q1 2021 May 17, 2021	BUY	$9.2 - $23.86 $327,520 - $849,416	35,600 Added 232.68%	50,900 $503,000
Q4 2020 Feb 16, 2021	BUY	$13.47 - $24.89 $72,738 - $134,406	5,400 Added 54.55%	15,300 $353,000
Q3 2020 Nov 16, 2020	SELL	$12.89 - $15.89 $145,657 - $179,557	-11,300 Reduced 53.3%	9,900 $140,000
Q2 2020 Aug 14, 2020	BUY	$8.86 - $15.69 $95,688 - $169,452	10,800 Added 103.85%	21,200 $320,000
Q1 2020 May 15, 2020	BUY	$6.63 - $11.16 $26,520 - $44,640	4,000 Added 62.5%	10,400 $96,000
Q4 2019 Feb 14, 2020	BUY	$7.48 - $10.75 $47,872 - $68,800	6,400 New	6,400 $62,000
Q2 2019 Aug 14, 2019	SELL	$10.96 - $14.4 $40,552 - $53,280	-3,700 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$10.04 - $13.92 $1.29 Million - $1.79 Million	-128,300 Reduced 97.2%	3,700 $50,000
Q4 2018 Feb 14, 2019	BUY	$8.38 - $13.44 $442,464 - $709,632	52,800 Added 66.67%	132,000 $1.27 Million
Q3 2018 Nov 14, 2018	SELL	$11.6 - $16.54 $649,600 - $926,240	-56,000 Reduced 41.42%	79,200 $958,000
Q2 2018 Aug 14, 2018	BUY	$13.13 - $17.09 $1.78 Million - $2.31 Million	135,200 New	135,200 $2.11 Million

Others Institutions Holding FOLD

# of Institutions

311

Shares Held

312M

Call Options Held

516K

Put Options Held

833K

Vanguard Group Inc Valley Forge, PA

28.8M
Shares

$277 Million
0.01% of portfolio
Perceptive Advisors LLC New York, NY

28.1M
Shares

$270 Million
7.83% of portfolio
Black Rock Inc. New York, NY

24.4M
Shares

$234 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

24M
Shares

$230 Million
0.05% of portfolio
Avoro Capital Advisors LLC New York, NY

23.2M
Shares

$223 Million
3.72% of portfolio

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.7B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.

Account